JP2022511951A5 - - Google Patents

Info

Publication number
JP2022511951A5
JP2022511951A5 JP2021533244A JP2021533244A JP2022511951A5 JP 2022511951 A5 JP2022511951 A5 JP 2022511951A5 JP 2021533244 A JP2021533244 A JP 2021533244A JP 2021533244 A JP2021533244 A JP 2021533244A JP 2022511951 A5 JP2022511951 A5 JP 2022511951A5
Authority
JP
Japan
Prior art keywords
growth hormone
receptor antagonist
human growth
hormone receptor
polyethylene glycol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021533244A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022511951A (ja
Filing date
Publication date
Priority claimed from US16/216,230 external-priority patent/US10874717B2/en
Application filed filed Critical
Priority claimed from PCT/US2019/065385 external-priority patent/WO2020123450A1/en
Publication of JP2022511951A publication Critical patent/JP2022511951A/ja
Publication of JP2022511951A5 publication Critical patent/JP2022511951A5/ja
Priority to JP2024195736A priority Critical patent/JP2025026898A/ja
Pending legal-status Critical Current

Links

JP2021533244A 2018-12-11 2019-12-10 Peg化された成長ホルモンアンタゴニスト Pending JP2022511951A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024195736A JP2025026898A (ja) 2018-12-11 2024-11-08 Peg化された成長ホルモンアンタゴニスト

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16/216,230 US10874717B2 (en) 2015-07-07 2018-12-11 Pegylated growth hormone antagonists
US16/216,230 2018-12-11
PCT/US2019/065385 WO2020123450A1 (en) 2018-12-11 2019-12-10 Pegylated growth hormone antagonists

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024195736A Division JP2025026898A (ja) 2018-12-11 2024-11-08 Peg化された成長ホルモンアンタゴニスト

Publications (2)

Publication Number Publication Date
JP2022511951A JP2022511951A (ja) 2022-02-01
JP2022511951A5 true JP2022511951A5 (https=) 2022-12-16

Family

ID=71076634

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021533244A Pending JP2022511951A (ja) 2018-12-11 2019-12-10 Peg化された成長ホルモンアンタゴニスト
JP2024195736A Pending JP2025026898A (ja) 2018-12-11 2024-11-08 Peg化された成長ホルモンアンタゴニスト

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024195736A Pending JP2025026898A (ja) 2018-12-11 2024-11-08 Peg化された成長ホルモンアンタゴニスト

Country Status (4)

Country Link
EP (1) EP3893919A4 (https=)
JP (2) JP2022511951A (https=)
CA (1) CA3121241A1 (https=)
WO (1) WO2020123450A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250101076A1 (en) * 2023-09-22 2025-03-27 Molecular Technologies Laboratories Llc Growth hormone receptor antagonists exhibiting increased receptor binding properties and increased serum half-life

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0507169A (pt) 2004-02-02 2007-06-26 Ambrx Inc polipeptìdeos do hormÈnio de crescimento humano modificados e seu usos
BRPI0519430A2 (pt) * 2004-12-22 2009-02-10 Ambrx Inc hormânio do crescimento humano modificado
US20170007711A1 (en) * 2015-07-07 2017-01-12 Richard S. Brody Pegylated growth hormone antagonists
US10874717B2 (en) 2015-07-07 2020-12-29 Burr Oak Therapeutics LLC Pegylated growth hormone antagonists
WO2019211842A1 (en) 2018-04-30 2019-11-07 Opko Biologics Ltd. Long-acting human growth hormone-antagonists and methods of producing the same

Similar Documents

Publication Publication Date Title
US12527746B2 (en) Peptide/particle delivery systems
JP6949711B2 (ja) ペプチドバリアントを含む医薬組成物及びその使用方法
JP6023703B2 (ja) 改善された安定性を有するフィブロネクチンをベースとする足場タンパク質
ES2397660T3 (es) Método para la producción de conjugados de factor I de crecimiento similar a la insulina y polietilenglicol
JP2011184442A (ja) Il−21の誘導体
JP2002527052A (ja) 改善された生物活性と生体適合性のためのタンパク質の部位特異的二重ポリエチレングリコール化
TW200529868A (en) N-terminally monopegylated human growth hormone conjugates, process for their preparation, and methods of use thereof
JP2020183404A (ja) 第viii因子両性イオンポリマーコンジュゲート
CA2708819A1 (en) An erythropoietin mimetic peptide derivative and its pharmaceutical salts, the preparation and uses thereof
TWI281864B (en) N-terminally monopegylated human growth hormone conjugates and process for their preparation
CN106795214A (zh) 稳定化的基于纤连蛋白的支架分子
JP2023512587A (ja) Panx1関連疾患の治療
US20170246311A1 (en) Peptides for binding alternatively activated macrophages
CN117355339A (zh) 用于将核酸有效细胞内递送至免疫细胞的树枝状肽缀合聚合物
JP2007533298A (ja) Il−21の誘導体
JP2022511951A5 (https=)
TWI720939B (zh) 長效型多肽及其生產和給藥的方法
JP4237703B2 (ja) インスリン様成長因子結合タンパク質−4及びポリ(エチレングリコール)の接合体
WO2019211842A1 (en) Long-acting human growth hormone-antagonists and methods of producing the same
TWI708611B (zh) 聚乙二醇化介白素-11之組合物及方法
TW202321274A (zh) 人類運鐵蛋白受體結合肽
WO2010074082A1 (ja) バソヒビン修飾体
RU2420308C2 (ru) Стабилизированные композиции ил-21
CN105367629B (zh) 一种促红细胞生成素模拟肽以及其制备方法和用途
WO2025049691A1 (en) Peptide-based coating molecules for stabilizing dna nanostructures and imparting biological activity